SyntekaBio Company Description

SyntekaBio, Inc. operates as a genomic big data and artificial intelligence drug discovery company.

It creates new drug candidates using DeepMatcher, an AI drug development platform that combines new drug development technology and genomic big data technology, such as biomarkers for individual cancer drug screening and disease susceptibility by immunotyping, pharmacogenomic typing, and predicting multi-omics information-based drug adverse effects, etc. The company also developing new antigen prediction technology that can be used together with therapeutic vaccines and cell therapy products, and prediction of antibody therapeutics.

SyntekaBio, Inc. was founded in 2009 and is headquartered in Daejeon, South Korea.

SyntekaBio, Inc.

Country	South Korea
Founded	2009
Industry	Computer Programming, Data Processing, And Other Computer Related Services
Employees	63

Contact Details

Address: 1903, 1, Expo-ro Daejeon, 34126 South Korea
Phone	82 70 7663 0958
Website	syntekabio.com

Stock Details

Ticker Symbol	226330
Exchange	KOSDAQ
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	7370